Stock Market & Financial Investment News

News Breaks February 14, 2013 05:46 EDT VNDA Vanda Pharmaceuticals upgraded to Buy from Hold at Jefferies Jefferies upgraded Vanda Pharmaceuticals citing positive sleep efficacy data for the company's tasimelteon drug. The firm raised its price target for shares to $6.00 from $3.50. News For VNDA From The Last 14 Days Check below for free stories on VNDA the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 22, 2013 09:59 EDT VNDA Vanda Pharmaceuticals management to meet with Lazard Capital Subscribe for More Information May 17, 2013 11:39 EDT VNDA High option volume stocks: GNK VNDA BYI ARUN BYI ILMN Subscribe for More Information 07:37 EDT VNDA Vanda Pharmaceuticals price target raised to $17 from $11 at Lazard Capital Subscribe for More Information May 9, 2013 06:59 EDT VNDA Vanda Pharmaceuticals sees FY13 operating expense $57M-$62M Subscribe for More Information 06:57 EDT VNDA Vanda Pharmaceuticals reports Q1 EPS (15c), consensus (25c) Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.